Beginning in CY 2017, section 1848(e)(6)(A)(i) of the Act required that the fee schedule areas used for payment in California must be Metropolitan Statistical Areas (MSAs) as defined by the Office of Management and Budget (OMB) as of December 31 of the previous year
They are provided for research and laboratory use only and are not intended to diagnose, treat, cure, or prevent any disease
NAD+ levels naturally decline with age and under chronic stress, which can contribute to mental health challenges, including: Low energy and fatigue Difficulty focusing or memory problems Mood swings or irritability Reduced resilience to stress How NAD+ Therapy Supports Mental Health NAD+ therapy involves intravenous (IV) administration or subcutaneous injections of NAD+, which directly boosts cellular levels
We received no comments addressing the proposed revision to 425.316(c)(2) introductory text, and we are finalizing this change without modification
After this period, its potency may begin to decline